Tag: cardiomyopathy

Articles

• BRCA1 and BRCA2 mutation carriers
• Factors influencing Adriamycin (doxorubicin) effectiveness
• Influence of BMI, metabolic syndrome and diabetes on TN prognosis

News

09/26/17

Black cumin enhances Adriamycin toxicity and reduces cardiomyopathy

08/09/16

Quercetin could interfere with Adriamycin treatment

05/30/12

Fish oil might promote Adriamycin-induced heart damage

03/08/12

Heart drug digoxin (digitalis) increases risk of breast cancer

02/15/12

Grapes might help protect against Adriamycin-induced heart damage

12/01/11

Herceptin + anthracycline chemo increases risk of cardiomyopathy

Studies

• FRUCTOSE EXACERBATES ANTHRACYCLINE AND HER-2 BLOCKING AGENT MEDIATED CARDIOTOXICITY THROUGH NLRP3 AND MYD88 MEDIATED PATHWAYS: NEW ROLES OF SWEETENERS IN CARDIO-ONCOLOGY Cite
  Maurea N, bisceglia i, Iovine M, Giordano V, GIACOBBE I, Arianna R, et al. FRUCTOSE EXACERBATES ANTHRACYCLINE AND HER-2 BLOCKING AGENT MEDIATED CARDIOTOXICITY THROUGH NLRP3 AND MYD88 MEDIATED PATHWAYS: NEW ROLES OF SWEETENERS IN CARDIO-ONCOLOGY. Journal of the American College of Cardiology. Elsevier BV; 2024; 83:2563 10.1016/s0735-1097(24)04553-4
• CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity Cite
  Liu C, Shen M, Liu Y, Manhas A, Zhao SR, Zhang M, et al. CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity. Cell Stem Cell. Elsevier BV; 2024; 31:1760-1776.e9 10.1016/j.stem.2024.10.007
• Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study Cite
  Cortés-Salgado A, Serrano JJ, Cordero Pereda D, Menacho M, Del Rey JM, del Campo-Albendea L, et al. Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study. The Oncologist. Oxford University Press (OUP); 2024; 10.1093/oncolo/oyae299
• Abstract 4147821: Physical Activity Impacts Cardiac Tissue Mitochondrial Respiration During Anthracycline Chemotherapy Cite
  Riojas A, Harbert S, Lacy J, Piloso J, Kramer P, Weis J, et al. Abstract 4147821: Physical Activity Impacts Cardiac Tissue Mitochondrial Respiration During Anthracycline Chemotherapy. Circulation. Ovid Technologies (Wolters Kluwer Health); 2024; 150 10.1161/circ.150.suppl_1.4147821
• Chamomile Extract Reduces Cardiac Toxicity in Female Mice with Ehrlich Solid Carcinoma Cite
  Abosharaf HA, Farag AM, Abdel Allem AAH, El-Sayed IET, Akela MA, Tousson E, et al. Chamomile Extract Reduces Cardiac Toxicity in Female Mice with Ehrlich Solid Carcinoma. Cell Biochemistry and Biophysics. Springer Science and Business Media LLC; 2024; 10.1007/s12013-024-01476-6
• Possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial Cite
  Kettana KM, El‑Haggar SM, Alm El-Din MA, El‑Afify DR. Possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial. Medical Oncology. Springer Science and Business Media LLC; 2024; 41 10.1007/s12032-024-02426-1
• Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis Cite
  Bucci T, Gue Y, Dobson R, Palmieri C, Pignatelli P, Lip GYH. Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis. Clinical and Experimental Medicine. Springer Science and Business Media LLC; 2024; 24 10.1007/s10238-024-01395-z
• Beta-blocker use and breast cancer outcomes: a meta-analysis Cite
  Scott OW, TinTin S, Cavadino A, Elwood JM. Beta-blocker use and breast cancer outcomes: a meta-analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07263-4
• Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study Cite
  Strell C, Smith DR, Valachis A, Woldeyesus H, Wadsten C, Micke P, et al. Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07358-y
• Heart Failure Post-Myocardial Infarction Promotes Mammary Tumor Growth Through the NGF-TRKA Pathway Cite
  Tani T, Oikawa M, Misaka T, Ishida T, Takeishi Y. Heart Failure Post-Myocardial Infarction Promotes Mammary Tumor Growth Through the NGF-TRKA Pathway. JACC: CardioOncology. Elsevier BV; 2024; 6:55-66 10.1016/j.jaccao.2023.10.002
• Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria Cite
  Li C, Stražar M, Mohamed AM, Pacheco JA, Walker RL, Lebar T, et al. Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria. Cell. Elsevier BV; 2024; 10.1016/j.cell.2024.03.014
• The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials Cite
  Amin AM, Khlidj Y, Abuelazm M, Ibrahim AA, Tanashat M, Imran M, et al. The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials. Cardio-Oncology. Springer Science and Business Media LLC; 2024; 10 10.1186/s40959-024-00208-2
• Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab Cite
  Zhou S, Cirne F, Chow J, Zereshkian A, Bordeleau L, Dhesy-Thind S, et al. Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab. The Oncologist. Oxford University Press (OUP); 2023; 28:e712-e722 10.1093/oncolo/oyad086
• The Impact of Chemotherapy on Cardiovascular Mortality across Breast Cancer Subtypes Cite
  Ngô TM, Lê ÁN, Đinh DPH. The Impact of Chemotherapy on Cardiovascular Mortality across Breast Cancer Subtypes. Current Oncology. MDPI AG; 2024; 31:649-659 10.3390/curroncol31020047
• Impact of Beta Blockers on Breast Cancer Incidence and Prognosis Cite
  Yang J, Zhang S, Jiang W. Impact of Beta Blockers on Breast Cancer Incidence and Prognosis. Clinical Breast Cancer. Elsevier BV; 2023; 23:664-671.e21 10.1016/j.clbc.2023.05.014
• Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions Cite
  Liu C, Chen H, Guo S, Liu Q, Chen Z, Huang H, et al. Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions. Biomedicine & Pharmacotherapy. Elsevier BV; 2023; 166:115373 10.1016/j.biopha.2023.115373
• Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients Cite
  Balaji S, Antony AK, Tonchev H, Scichilone G, Morsy M, Deen H, et al. Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients. Biomedicines. MDPI AG; 2023; 11:2286 10.3390/biomedicines11082286
• Use of calcium channel blockers does not increase breast cancer risk: findings from a nationwide population-based cohort study in Taiwan Cite
  Minegishi S. Use of calcium channel blockers does not increase breast cancer risk: findings from a nationwide population-based cohort study in Taiwan. Hypertension Research. Springer Science and Business Media LLC; 2023; 10.1038/s41440-023-01382-z
• Association between insulin resistance and cardiac remodeling in HER2-positive breast cancer patients: a real-world study Cite
  Shi Y, Qiu Z, Yu J, Li Z, Hua S, Chen Y, et al. Association between insulin resistance and cardiac remodeling in HER2-positive breast cancer patients: a real-world study. BMC Cancer. Springer Science and Business Media LLC; 2023; 23 10.1186/s12885-023-11102-y
• Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study Cite
  Hsieh H, Wu T, Chen C, Kuo Y, Hour M. Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study. Therapeutic Advances in Drug Safety. SAGE Publications; 2023; 14 10.1177/20420986231181338
• Use of calcium channel blockers and risk of breast cancer among women aged 55 years and older: a nationwide population-based cohort study Cite
  Lin S, Huang H, Chiang L, Huang L, Wang C. Use of calcium channel blockers and risk of breast cancer among women aged 55 years and older: a nationwide population-based cohort study. Hypertension Research. Springer Science and Business Media LLC; 2023; 10.1038/s41440-023-01321-y
• Mechanism of Saffron Extract against Cardiotoxicity Induced by Doxorubicin: 4D Label-Free Quantitative proteomics Analysis and Bioinformatic Study Cite
  Sa R, Lin Z, Huang J, Wang Y, Lv J, Zhang X, et al. Mechanism of Saffron Extract against Cardiotoxicity Induced by Doxorubicin: 4D Label-Free Quantitative proteomics Analysis and Bioinformatic Study. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-2580481/v1
• Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010 Cite
  Larsen CM, Garcia Arango M, Dasari H, Arciniegas Calle M, Adjei E, Rico Mesa J, et al. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010. JAMA Network Open. American Medical Association (AMA); 2023; 6:e2254669 10.1001/jamanetworkopen.2022.54669
• An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity Cite
  Benedetto N, Calabrone L, Gutmańska K, Macrì N, Cerrito MG, Ricotta R, et al. An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity. Frontiers in Cardiovascular Medicine. Frontiers Media SA; 2022; 9 10.3389/fcvm.2022.867867
• Melatonin and metformin ameliorated trastuzumab-induced cardiotoxicity through the modulation of mitochondrial function and dynamics without reducing its anticancer efficacy Cite
  Arinno A, Maneechote C, Khuanjing T, Prathumsap N, Chunchai T, Arunsak B, et al. Melatonin and metformin ameliorated trastuzumab-induced cardiotoxicity through the modulation of mitochondrial function and dynamics without reducing its anticancer efficacy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Elsevier BV; 2023; 1869:166618 10.1016/j.bbadis.2022.166618
• Exercise for the Prevention of Anthracycline-induced Functional Disability and Cardiac Dysfunction: The BReast Cancer Randomized EXercise InTervention (BREXIT) Study Cite
  Foulkes SJ, Howden EJ, Haykowsky MJ, Antill Y, Salim A, Nightingale SS, et al. Exercise for the Prevention of Anthracycline-induced Functional Disability and Cardiac Dysfunction: The BReast Cancer Randomized EXercise InTervention (BREXIT) Study. Circulation. Ovid Technologies (Wolters Kluwer Health); 2022; 10.1161/circulationaha.122.062814
• Potential Cardioprotective Effects and Lipid Mediator Differences in Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplemented Mice Given Chemotherapy Cite
  Angelotti A, Snoke DB, Ormiston K, Cole RM, Borkowski K, Newman JW, et al. Potential Cardioprotective Effects and Lipid Mediator Differences in Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplemented Mice Given Chemotherapy. Metabolites. MDPI AG; 2022; 12:782 10.3390/metabo12090782
• Cardioprotective effects of Ferulic acid against various drugs and toxic agents Cite
  Pandi A, Raghu MH, Chandrashekar N, Kalappan VM. Cardioprotective effects of Ferulic acid against various drugs and toxic agents. Beni-Suef University Journal of Basic and Applied Sciences. Springer Science and Business Media LLC; 2022; 11 10.1186/s43088-022-00273-5
• β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis Cite
  Løfling LL, Støer NC, Sloan EK, Chang A, Gandini S, Ursin G, et al. β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis. British Journal of Cancer. Springer Science and Business Media LLC; 2022; 10.1038/s41416-022-01891-7
• Effects of exercise during adjuvant chemotherapy for breast cancer on long-term cardiotoxicity. Cite
  Naaktgeboren W, Stuiver MM, van Harten WH, Aaronson NK, Scott J, Sonke GS, et al. Effects of exercise during adjuvant chemotherapy for breast cancer on long-term cardiotoxicity.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 40:12081-12081 10.1200/jco.2022.40.16_suppl.12081
• Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: a randomized controlled trial in breast cancer patients Cite
  Werida RH, Elshafiey RA, Ghoneim A, Elzawawy S, Mostafa TM. Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: a randomized controlled trial in breast cancer patients. Supportive Care in Cancer. Springer Science and Business Media LLC; 2022; 10.1007/s00520-022-07124-0
• Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors Cite
  Nijhof AVO-, Jacobse JN, Steggink LC, Lefrandt JD, Gietema JA, Leeuwen FEV, et al. Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1626546/v1
• Protective Effect of Curcumin, Chrysin and Thymoquinone Injection on Trastuzumab-Induced Cardiotoxicity via Mitochondrial Protection Cite
  Shirmard LR, Shabani M, Moghadam AA, Zamani N, Ghanbari H, Salimi A. Protective Effect of Curcumin, Chrysin and Thymoquinone Injection on Trastuzumab-Induced Cardiotoxicity via Mitochondrial Protection. Cardiovascular Toxicology. Springer Science and Business Media LLC; 2022; 10.1007/s12012-022-09750-w
• Phloretin-induced suppression of oxidative and nitrosative stress attenuates doxorubicin-induced cardiotoxicity in rats Cite
  Patil C, Wagh S, Patil K, Mahajan U, Bagal P, Wadkar A, et al. Phloretin-induced suppression of oxidative and nitrosative stress attenuates doxorubicin-induced cardiotoxicity in rats. Asian Pacific Journal of Tropical Biomedicine. Medknow; 2022; 12:124 10.4103/2221-1691.338921
• Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice Cite
  Eekhoudt CR, Bortoluzzi T, Varghese SS, Cheung DYC, Christie S, Eastman S, et al. Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice. Current Oncology. MDPI AG; 2022; 29:2941-2953 10.3390/curroncol29050241
• Isoorientin attenuates doxorubicin-induced cardiac injury via the activation of MAPK, Akt, and Caspase-dependent signaling pathways Cite
  Li S, Liu H, Lin Z, Li Z, Chen Y, Chen B, et al. Isoorientin attenuates doxorubicin-induced cardiac injury via the activation of MAPK, Akt, and Caspase-dependent signaling pathways. Phytomedicine. Elsevier BV; 2022; 101:154105 10.1016/j.phymed.2022.154105
• Diet impacts triple‐negative breast cancer growth, metastatic potential, chemotherapy responsiveness, and doxorubicin‐mediated cardiac dysfunction Cite
  Ramirez MU, Clear KYJ, Cornelius Z, Bawaneh A, Feliz‐Mosquea YR, Wilson AS, et al. Diet impacts triple‐negative breast cancer growth, metastatic potential, chemotherapy responsiveness, and doxorubicin‐mediated cardiac dysfunction. Physiological Reports. Wiley; 2022; 10 10.14814/phy2.15192
• Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study Cite
  Greenlee H, Iribarren C, Rana JS, Cheng R, Nguyen-Huynh M, Rillamas-Sun E, et al. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 10.1200/jco.21.01736
• Abstract P5-18-12: Cardioprotective effects of walnuts against aromatase inhibitor: Pilot study in a zebrafish model Cite
  Hilakivi-Clarke L, Da Silva JL, Blaes A, Hoeppner L. Abstract P5-18-12: Cardioprotective effects of walnuts against aromatase inhibitor: Pilot study in a zebrafish model. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P5-18-12-P5-18-12 10.1158/1538-7445.sabcs21-p5-18-12
• Hesperidin protects against cisplatin-induced cardiotoxicity in mice by regulating the p62–Keap1–Nrf2 pathway Cite
  Jia Y, Guo H, Cheng X, Zhang Y, Si M, Shi J, et al. Hesperidin protects against cisplatin-induced cardiotoxicity in mice by regulating the p62–Keap1–Nrf2 pathway. Food & Function. Royal Society of Chemistry (RSC); 2022; 10.1039/d2fo00298a
• Natural Polysaccharide β-Glucan Protects against Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress Cite
  Wang X, Ji Y, Jin D, Qi J, Hou X, Zhao W, et al. Natural Polysaccharide β-Glucan Protects against Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress. Nutrients. MDPI AG; 2022; 14:906 10.3390/nu14040906
• Trends in heart disease mortality among breast cancer survivors in the US, 1975–2017 Cite
  Vo JB, Ramin C, Barac A, Berrington de Gonzalez A, Veiga L. Trends in heart disease mortality among breast cancer survivors in the US, 1975–2017. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06515-5
• Prevention of doxorubicin-induced experimental cardiotoxicity by Nigella sativa in rats Cite
  Adıyaman MŞ, Adıyaman ÖA, Dağlı AF, Karahan MZ, Dağlı MN. Prevention of doxorubicin-induced experimental cardiotoxicity by Nigella sativa in rats. Revista Portuguesa de Cardiologia. Elsevier BV; 2022; 10.1016/j.repc.2020.12.015
• Use of beta‐blockers and risk of contralateral breast cancer Cite
  Gottschau M, Bens A, Friis S, Cronin‐Fenton D, Aalborg GL, Jensen M, et al. Use of beta‐blockers and risk of contralateral breast cancer. International Journal of Cancer. Wiley; 2022; 10.1002/ijc.33923
• Letrozole Accelerates Metabolic Remodeling through Activation of Glycolysis in Cardiomyocytes: A Role beyond Hormone Regulation Cite
  Heo JH, Lee SR, Jo SL, Yang H, Lee HW, Hong E. Letrozole Accelerates Metabolic Remodeling through Activation of Glycolysis in Cardiomyocytes: A Role beyond Hormone Regulation. International Journal of Molecular Sciences. MDPI AG; 2022; 23:547 10.3390/ijms23010547
• Overexpression of Neuron-Derived Orphan Receptor 1 (NOR-1) Rescues Cardiomyocytes from Cell Death and Improves Viability after Doxorubicin Induced Stress Cite
  Berg P, Hansson ÅML, Røsand Ø, Marwarha G, Høydal MA. Overexpression of Neuron-Derived Orphan Receptor 1 (NOR-1) Rescues Cardiomyocytes from Cell Death and Improves Viability after Doxorubicin Induced Stress. Biomedicines. MDPI AG; 2021; 9:1233 10.3390/biomedicines9091233
• Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway Cite
  Shabaan DA, Mostafa N, El-Desoky MM, Arafat EA. Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway. Tissue Barriers. Informa UK Limited; 2021; 10.1080/21688370.2021.2019504
• Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-κB, and TNF-α in Rats Cite
  Ibrahim Fouad G, Ahmed KA. Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-κB, and TNF-α in Rats. Cardiovascular Toxicology. Springer Science and Business Media LLC; 2021; 10.1007/s12012-021-09710-w
• Cardiac Risk Factors in Black Women With Breast Cancer Undergoing Proton Therapy (PBT): Potential for Increased Therapeutic Gain Cite
  Nichols E, DeCesaris C, Paulosky K, McAvoy S, Ruff S, Vyfhuis M. Cardiac Risk Factors in Black Women With Breast Cancer Undergoing Proton Therapy (PBT): Potential for Increased Therapeutic Gain. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2021; 111:e328 10.1016/j.ijrobp.2021.07.1005
• Exercise to Reduce Anthracycline-Mediated Cardiovascular Complications in Breast Cancer Survivors Cite
  Varghese SS, Johnston WJ, Eekhoudt CR, Keats MR, Jassal DS, Grandy SA. Exercise to Reduce Anthracycline-Mediated Cardiovascular Complications in Breast Cancer Survivors. Current Oncology. MDPI AG; 2021; 28:4139-4156 10.3390/curroncol28050351
• Cardioprotective effect of allyl isothiocyanate in a rat model of doxorubicin acute toxicity Cite
  Waz S, Matouk AI. Cardioprotective effect of allyl isothiocyanate in a rat model of doxorubicin acute toxicity. Toxicology Mechanisms and Methods. Informa UK Limited; 2021;:1-25 10.1080/15376516.2021.1992064
• Modulation of interaction of BRCA1-RAD51 and BRCA1-AURKA protein complexes by natural metabolites using as possible therapeutic intervention toward cardiotoxic effects of cancer drugs: an in-silico approach Cite
  Tiwari S, Pandey VP, Yadav K, Dwivedi UN. Modulation of interaction of BRCA1-RAD51 and BRCA1-AURKA protein complexes by natural metabolites using as possible therapeutic intervention toward cardiotoxic effects of cancer drugs: an in-silico approach. Journal of Biomolecular Structure and Dynamics. Informa UK Limited; 2021;:1-17 10.1080/07391102.2021.1976278
• A careful reassessment of anthracycline use in curable breast cancer Cite
  Hurvitz SA, McAndrew NP, Bardia A, Press MF, Pegram M, Crown JP, et al. A careful reassessment of anthracycline use in curable breast cancer. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00342-5
• Association between cardiac autonomic modulation and sedentary behavior in breast cancer survivors: a 12-month cohort study Cite
  Palma MR, Tebar WR, Vanderlei LCM, Fregonesi CEPT, Ribeiro FE, Caldeira DT, et al. Association between cardiac autonomic modulation and sedentary behavior in breast cancer survivors: a 12-month cohort study. Supportive Care in Cancer. Springer Science and Business Media LLC; 2021; 10.1007/s00520-021-06602-1
• The Potential protective role of astaxanthin on doxorubicin-induced cardiac toxicity in rats Cite
  Derias MSM, Sabaa AERFA, Osman AEMMA, Mohamed AEA, Abou-bakr Darwish DA. The Potential protective role of astaxanthin on doxorubicin-induced cardiac toxicity in rats. QJM: An International Journal of Medicine. Oxford University Press (OUP); 2021; 114 10.1093/qjmed/hcab117.003
• Protective effect of limonin against doxorubicin-induced cardiotoxicity via activating Nuclear factor - like 2 and Sirtuin 2 signaling pathways Cite
  Deng J, Huang M, Wu H. Protective effect of limonin against doxorubicin-induced cardiotoxicity via activating Nuclear factor - like 2 and Sirtuin 2 signaling pathways. Bioengineered. Informa UK Limited; 2021; 10.1080/21655979.2021.1985299
• Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis Cite
  Koelwyn GJ, Aboumsallem JP, Moore KJ, de Boer RA. Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis. Journal of Molecular and Cellular Cardiology. Elsevier BV; 2021; 10.1016/j.yjmcc.2021.09.008
• 523Use of beta blockers and death from breast cancer in New Zealand breast cancer patients Cite
  Scott O, TinTin S, Cavadino A, Elwood M. 523Use of beta blockers and death from breast cancer in New Zealand breast cancer patients. International Journal of Epidemiology. Oxford University Press (OUP); 2021; 50 10.1093/ije/dyab168.587
• Cognitive Dysfunction after Heart Disease: A Manifestation of the Heart-Brain Axis Cite
  Xu C, Tao X, Ma X, Zhao R, Cao Z. Cognitive Dysfunction after Heart Disease: A Manifestation of the Heart-Brain Axis. Oxidative Medicine and Cellular Longevity. Hindawi Limited; 2021; 2021:1-10 10.1155/2021/4899688
• Acute toxicity and tolerability of anthracycline-based chemotherapy regimens in older versus younger patients with breast cancer: real-world data Cite
  Monteiro AR, Garcia AR, Póvoa S, Soares RF, Macedo F, Pereira TC, et al. Acute toxicity and tolerability of anthracycline-based chemotherapy regimens in older versus younger patients with breast cancer: real-world data. Supportive Care in Cancer. Springer Science and Business Media LLC; 2020; 29:2347-2353 10.1007/s00520-020-05766-6
• Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer Cite
  Lorona NC, Cook LS, Tang MC, Hill DA, Wiggins CL, Li CI. Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer. Cancer Causes & Control. Springer Science and Business Media LLC; 2021; 10.1007/s10552-021-01485-3
• Antioxidant, anti-inflammatory, and anti-apoptotic effects of crocin against doxorubicin-induced myocardial toxicity in rats Cite
  Abdulkareem Aljumaily SA, Demir M, Elbe H, Yigitturk G, Bicer Y, Altinoz E. Antioxidant, anti-inflammatory, and anti-apoptotic effects of crocin against doxorubicin-induced myocardial toxicity in rats. Environmental Science and Pollution Research. Springer Science and Business Media LLC; 2021; 10.1007/s11356-021-15409-w
• Anthocyanins from purple sweet potato alleviate doxorubicin‐induced cardiotoxicity in vitro and in vivo Cite
  Tang S, Kan J, Sun R, Cai H, Hong J, Jin C, et al. Anthocyanins from purple sweet potato alleviate doxorubicin‐induced cardiotoxicity in vitro and in vivo. Journal of Food Biochemistry. Wiley; 2021; 10.1111/jfbc.13869
• Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study Cite
  Sund M, Garcia-Argibay M, Garmo H, Ahlgren J, Wennstig A, Fredriksson I, et al. Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study. The Breast. Elsevier BV; 2021; 59:157-164 10.1016/j.breast.2021.07.004
• In Vivo and In Vitro Protective Effects of Rosmarinic Acid against Doxorubicin-Induced Cardiotoxicity Cite
  Rahbardar MG, Eisvand F, Rameshrad M, Razavi BM, Hosseinzadeh H. In Vivo and In Vitro Protective Effects of Rosmarinic Acid against Doxorubicin-Induced Cardiotoxicity. Nutrition and Cancer. Informa UK Limited; 2021;:1-15 10.1080/01635581.2021.1931362
• Antioxidant, anti-inflammatory and anti-apoptotic effects of crocin against doxorubicin-induced myocardial toxicity in rats Cite
  ALJUMAILY SAA, Demir M, Elbe H, Yigitturk G, Bicer Y, Altinoz E. Antioxidant, anti-inflammatory and anti-apoptotic effects of crocin against doxorubicin-induced myocardial toxicity in rats. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-418902/v1
• Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer Cite
  Battisti NML, Andres MS, Lee KA, Ramalingam S, Nash T, Mappouridou S, et al. Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06192-w
• Morphine Deteriorates Cisplatin-Induced Cardiotoxicity in Rats and Induces Dose-Dependent Cisplatin Chemoresistance in MCF-7 Human Breast Cancer Cells Cite
  El-Sheikh AAK, Khired Z. Morphine Deteriorates Cisplatin-Induced Cardiotoxicity in Rats and Induces Dose-Dependent Cisplatin Chemoresistance in MCF-7 Human Breast Cancer Cells. Cardiovascular Toxicology. Springer Science and Business Media LLC; 2021; 10.1007/s12012-021-09646-1
• Beta-blockers use and risk of breast cancer in women with hypertension Cite
  Zheng G, Sundquist J, Sundquist K, Ji J. Beta-blockers use and risk of breast cancer in women with hypertension. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.1599.2020 10.1158/1055-9965.epi-20-1599
• High intensity exercise during breast cancer chemotherapy - effects on long-term myocardial damage and physical capacity - data from the OptiTrain RCT Cite
  Ansund J, Mijwel S, Bolam KA, Altena R, Wengström Y, Rullman E, et al. High intensity exercise during breast cancer chemotherapy - effects on long-term myocardial damage and physical capacity - data from the OptiTrain RCT. Cardio-Oncology. Springer Science and Business Media LLC; 2021; 7 10.1186/s40959-021-00091-1
• Racial and Socioeconomic Disparities in Cardiotoxicity among Women with HER2-Positive Breast Cancer Cite
  Al-Sadawi M, Hussain Y, Copeland-Halperin RS, Tobin JN, Moskowitz CS, Dang CT, et al. Racial and Socioeconomic Disparities in Cardiotoxicity among Women with HER2-Positive Breast Cancer. The American Journal of Cardiology. Elsevier BV; 2021; 10.1016/j.amjcard.2021.02.013
• CAN ANTIOXIDANT VITAMINS AVOID THE DOXORUBICIN CARDIOTOXICITY IN THE BREAST CANCER TREATMENT? Cite
  Lima Cavalcanti ID, Santos Soares JC, de Fátima Ramos dos Santos Medeiros SM, Ferro Cavalcanti IM, de Britto Lira Nogueira MC. CAN ANTIOXIDANT VITAMINS AVOID THE DOXORUBICIN CARDIOTOXICITY IN THE BREAST CANCER TREATMENT?. PharmaNutrition. Elsevier BV; 2021;:100259 10.1016/j.phanu.2021.100259
• Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors Cite
  Kim KH, Choi S, Kim K, Chang J, Kim SM, Kim SR, et al. Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06140-8
• Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study Cite
  Abdel‐Qadir H, Bobrowski D, Zhou L, Austin PC, Calvillo‐Argüelles O, Amir E, et al. Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study. Journal of the American Heart Association. Ovid Technologies (Wolters Kluwer Health); 2021; 10.1161/jaha.119.018393
• Ouabain and Digoxin Activate the Proteasome and the Degradation of the ERα in Cells Modeling Primary and Metastatic Breast Cancer Cite
  Busonero C, Leone S, Bianchi F, Maspero E, Fiocchetti M, Palumbo O, et al. Ouabain and Digoxin Activate the Proteasome and the Degradation of the ERα in Cells Modeling Primary and Metastatic Breast Cancer. Cancers. MDPI AG; 2020; 12:3840 10.3390/cancers12123840
• Melatonin prevents doxorubicin-induced cardiotoxicity through suppression of AMPKα2-dependent mitochondrial damage Cite
  Yang G, Song M, Hoang DH, Tran QH, Choe W, Kang I, et al. Melatonin prevents doxorubicin-induced cardiotoxicity through suppression of AMPKα2-dependent mitochondrial damage. Experimental & Molecular Medicine. Springer Science and Business Media LLC; 2020; 10.1038/s12276-020-00541-3
• Plasma Magnesium Concentrations and Risk of Incident Cancer in Adults with Hypertension: A Nested Case-Control Study Cite
  Lin T, Bi C, Song Y, Guo H, Liu L, Zhou Z, et al. Plasma Magnesium Concentrations and Risk of Incident Cancer in Adults with Hypertension: A Nested Case-Control Study. Annals of Nutrition and Metabolism. S. Karger AG; 2020;:1-9 10.1159/000510214
• Angiotensin Receptor Blockers Associated with Improved Breast Cancer Survival—A Nationwide Cohort Study from Finland Cite
  Santala EE, Murto MO, Artama M, Pukkala E, Visvanathan K, Murtola TJ. Angiotensin Receptor Blockers Associated with Improved Breast Cancer Survival—A Nationwide Cohort Study from Finland. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020; 29:2376-2382 10.1158/1055-9965.epi-20-0711
• The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data Cite
  Modi ND, Tan JQE, Rowland A, Koczwara B, Kichenadasse G, McKinnon RA, et al. The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data. Frontiers in Oncology. Frontiers Media SA; 2020; 10 10.3389/fonc.2020.01130
• Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study Cite
  Jacobse JN, Schaapveld M, Boekel NB, Hooning MJ, Jager A, Baaijens MHA, et al. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05930-w
• Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner Cite
  Yu W, Qin X, Zhang Y, Qiu P, Wang L, Zha W, et al. Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner. Cardiovascular Diagnosis and Therapy. AME Publishing Company; 2020; 10:752-769 10.21037/cdt-19-707
• Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity Cite
  Sergazy S, Shulgau Z, Fedotovskikh G, Chulenbayeva L, Nurgozhina A, Nurgaziyev M, et al. Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity. Scientific Reports. Springer Science and Business Media LLC; 2020; 10 10.1038/s41598-020-71827-9
• Side effects of adjuvant chemotherapy and their impact on outcome in elderly breast cancer patients: a cohort study Cite
  Zanuso V, Fregoni V, Gervaso L. Side effects of adjuvant chemotherapy and their impact on outcome in elderly breast cancer patients: a cohort study. Future Science OA. Future Science Ltd; 2020;:FSO617 10.2144/fsoa-2020-0076
• Myocardial infarction promotes breast cancer recurrence Cite
  Romero D. Myocardial infarction promotes breast cancer recurrence. Nature Reviews Clinical Oncology. Springer Science and Business Media LLC; 2020; 17:520-520 10.1038/s41571-020-0418-7
• Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling Cite
  Maayah ZH, Takahara S, Alam AS, Ferdaoussi M, Sutendra G, El-Kadi AOS, et al. Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling. BMC Cancer. Springer Science and Business Media LLC; 2020; 20 10.1186/s12885-020-07217-1
• Myocardial infarction accelerates breast cancer via innate immune reprogramming Cite
  Koelwyn GJ, Newman AAC, Afonso MS, van Solingen C, Corr EM, Brown EJ, et al. Myocardial infarction accelerates breast cancer via innate immune reprogramming. Nature Medicine. Springer Science and Business Media LLC; 2020; 26:1452-1458 10.1038/s41591-020-0964-7
• Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol Cite
  Foulkes SJ, Howden EJ, Antill Y, Loi S, Salim A, Haykowsky MJ, et al. Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol. BMC Cancer. Springer Science and Business Media LLC; 2020; 20 10.1186/s12885-020-07123-6
• The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice Cite
  Asselin CY, Lam A, Cheung DYC, Eekhoudt CR, Zhu A, Mittal I, et al. The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice. The Journal of Nutrition. Oxford University Press (OUP); 2020; 150:2353-2363 10.1093/jn/nxaa144
• A Polyphenol-Rich Muscadine Grape Extract Inhibits HER + Breast Cancer and Protects Against Trastuzumab-Induced Cardiotoxicity Cite
  Mackert J, Gallagher P, Tallant E. A Polyphenol-Rich Muscadine Grape Extract Inhibits HER + Breast Cancer and Protects Against Trastuzumab-Induced Cardiotoxicity. Current Developments in Nutrition. Oxford University Press (OUP); 2020; 4:334-334 10.1093/cdn/nzaa044_033
• Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients Cite
  Cho H, Lee S, Sim SH, Park IH, Lee KS, Kwak MH, et al. Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 182:333-343 10.1007/s10549-020-05703-5
• Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects Cite
  Calcabrini C, Maffei F, Turrini E, Fimognari C. Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects. Frontiers in Pharmacology. Frontiers Media SA; 2020; 11 10.3389/fphar.2020.00567
• Crocin protects against cardiotoxicity induced by doxorubicin through TLR-2/NF-κB signal pathway in vivo and vitro Cite
  Chu X, Zhang Y, Xue Y, Li Z, Shi J, Wang H, et al. Crocin protects against cardiotoxicity induced by doxorubicin through TLR-2/NF-κB signal pathway in vivo and vitro. International Immunopharmacology. Elsevier BV; 2020; 84:106548 10.1016/j.intimp.2020.106548
• Agonist Effects of Propranolol on Non-Tumor Human Breast Cells Cite
  Gargiulo L, Rivero EM, di Siervi N, Buzzi ED, Buffone MG, Davio CA, et al. Agonist Effects of Propranolol on Non-Tumor Human Breast Cells. Cells. MDPI AG; 2020; 9:1036 10.3390/cells9041036
• Coenzyme Q10 in association with metabolism-related AMPK/PFKFB3 and angiogenic VEGF/VEGFR2 genes in breast cancer patients Cite
  Abdi S, Montazeri V, Garjani A, Shayanfar A, Pirouzpanah S. Coenzyme Q10 in association with metabolism-related AMPK/PFKFB3 and angiogenic VEGF/VEGFR2 genes in breast cancer patients. Molecular Biology Reports. Springer Science and Business Media LLC; 2020; 47:2459-2473 10.1007/s11033-020-05310-z
• Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries Cite
  Henson KE, McGale P, Darby SC, Parkin M, Wang Y, Taylor CW. Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries. International Journal of Cancer. Wiley; 2020; 147:1437-1449 10.1002/ijc.32908
• Exercise Intolerance in Anthracycline‐Treated Breast Cancer Survivors: The Role of Skeletal Muscle Bioenergetics, Oxygenation, and Composition Cite
  Beaudry RI, Kirkham AA, Thompson RB, Grenier JG, Mackey JR, Haykowsky MJ. Exercise Intolerance in Anthracycline‐Treated Breast Cancer Survivors: The Role of Skeletal Muscle Bioenergetics, Oxygenation, and Composition. The Oncologist. Wiley; 2020; 25 10.1634/theoncologist.2019-0777
• Anticoagulants and Breast Cancer Survival: A Nationwide Cohort Study Cite
  Kinnunen PT, Murto MO, Artama M, Pukkala E, Visvanathan K, Murtola TJ. Anticoagulants and Breast Cancer Survival: A Nationwide Cohort Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2019; 29:208-215 10.1158/1055-9965.epi-19-0147
• Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study Cite
  Kaboré EG, Guenancia C, Vaz-Luis I, Di Meglio A, Pistilli B, Coutant C, et al. Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study. PLOS Medicine. Public Library of Science (PLoS); 2019; 16:e1002989 10.1371/journal.pmed.1002989
• Causes of death after breast cancer diagnosis: A US population‐based analysis Cite
  Afifi AM, Saad AM, Al‐Husseini MJ, Elmehrath AO, Northfelt DW, Sonbol MB. Causes of death after breast cancer diagnosis: A US population‐based analysis. Cancer. Wiley; 2019; 126:1559-1567 10.1002/cncr.32648
• The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review Cite
  Najafi M, Hooshangi Shayesteh MR, Mortezaee K, Farhood B, Haghi-Aminjan H. The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review. Life Sciences. Elsevier BV; 2020; 241:117173 10.1016/j.lfs.2019.117173
• Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review Cite
  Spini A, Roberto G, Gini R, Bartolini C, Bazzani L, Donnini S, et al. Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review. Neoplasma. AEPress, s.r.o.; 2019; 66:963-970 10.4149/neo_2019_190110n34
• Fucoxanthin attenuates doxorubicin-induced cardiotoxicity via anti-oxidant and anti-apoptotic mechanisms associated with p38, JNK and p53 pathways Cite
  Zhao Y, Zhang L, Zhao G, Chen Y, Sun K, Wang B. Fucoxanthin attenuates doxorubicin-induced cardiotoxicity via anti-oxidant and anti-apoptotic mechanisms associated with p38, JNK and p53 pathways. Journal of Functional Foods. Elsevier BV; 2019; 62:103542 10.1016/j.jff.2019.103542
• Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat Cite
  Botelho AFM, Lempek MR, Branco SEMT, Nogueira MM, de Almeida ME, Costa AG, et al. Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat. Cardiovascular Toxicology. Springer Science and Business Media LLC; 2019; 20:222-234 10.1007/s12012-019-09547-4
• Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer Cite
  Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Fujita H, et al. Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer. BMC Cancer. Springer Science and Business Media LLC; 2019; 19 10.1186/s12885-019-5828-5
• Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer Cite
  Guglin M, Krischer J, Tamura R, Fink A, Bello-Matricaria L, McCaskill-Stevens W, et al. Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer. Journal of the American College of Cardiology. Elsevier BV; 2019; 73:2859-2868 10.1016/j.jacc.2019.03.495
• Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer Cite
  Troeschel AN, Liu Y, Collin LJ, Bradshaw PT, Ward KC, Gogineni K, et al. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer. International Journal of Epidemiology. Oxford University Press (OUP); 2019; 48:1897-1905 10.1093/ije/dyz108
• Cardioprotective Effect of Marine Astaxanthin on Doxorubicin-Induced Cardiotoxicity in Normal Rats Cite
  AlQahtani AA, Osman AM, Damanhouri ZA, Al-Kreathy HM, Al-Malky HS, Ramadan WS, et al. Cardioprotective Effect of Marine Astaxanthin on Doxorubicin-Induced Cardiotoxicity in Normal Rats. Journal of Pharmaceutical Research International. Sciencedomain International; 2019;:1-11 10.9734/jpri/2019/v27i330170
• Beta blockade as adjunctive breast cancer therapy: A review Cite
  Phadke S, Clamon G. Beta blockade as adjunctive breast cancer therapy: A review. Critical Reviews in Oncology/Hematology. Elsevier BV; 2019; 138:173-177 10.1016/j.critrevonc.2019.04.006
• Ferulic acid ameliorates doxorubicin-induced cardiac toxicity in rats Cite
  Aswar U, Mahajan U, Kandhare A, Aswar M. Ferulic acid ameliorates doxorubicin-induced cardiac toxicity in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. Springer Science and Business Media LLC; 2019; 392:659-668 10.1007/s00210-019-01623-4
• Milk and kefir maintain aspects of health during doxorubicin treatment in rats Cite
  Stewart L, Smoak P, Hydock D, Hayward R, O'Brien K, Lisano J, et al. Milk and kefir maintain aspects of health during doxorubicin treatment in rats. Journal of Dairy Science. American Dairy Science Association; 2019; 102:1910-1917 10.3168/jds.2018-15576
• AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis Cite
  Liu D, Ma Z, Di S, Yang Y, Yang J, Xu L, et al. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis. Free Radical Biology and Medicine. Elsevier BV; 2018; 129:59-72 10.1016/j.freeradbiomed.2018.08.032
• Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy Cite
  Calvillo-Argüelles O, Abdel-Qadir H, Michalowska M, Billia F, Suntheralingam S, Amir E, et al. Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy. Canadian Journal of Cardiology. Elsevier BV; 2018; 35:153-159 10.1016/j.cjca.2018.11.028
• A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study Cite
  Lidbrink E, Chmielowska E, Otremba B, Bouhlel A, Lauer S, Liste Hermoso M, et al. A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 174:187-196 10.1007/s10549-018-5058-6
• β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms Cite
  Xie W, He R, Zhang J, He Y, Wan Z, Zhou C, et al. β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms. Oncology Reports. Spandidos Publications; 2018; 10.3892/or.2018.6830
• Carvedilol suppresses malignant proliferation of mammary epithelial cells through inhibition of the ROS‑mediated PI3K/AKT signaling pathway Cite
  Ma Z, Liu X, Zhang Q, Yu Z, Gao D. Carvedilol suppresses malignant proliferation of mammary epithelial cells through inhibition of the ROS‑mediated PI3K/AKT signaling pathway. Oncology Reports. Spandidos Publications; 2018; 10.3892/or.2018.6873
• Wild edible onions — Allium flavum and Allium carinatum — successfully prevent adverse effects of chemotherapeutic drug doxorubicin Cite
  Aleksandar P, Dragana M, Nebojša J, Biljana N, Nataša S, Branka V, et al. Wild edible onions — Allium flavum and Allium carinatum — successfully prevent adverse effects of chemotherapeutic drug doxorubicin. Biomedicine & Pharmacotherapy. Elsevier BV; 2019; 109:2482-2491 10.1016/j.biopha.2018.11.106
• Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review Cite
  Matthews A, Stanway S, Farmer RE, Strongman H, Thomas S, Lyon AR, et al. Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review. BMJ. BMJ; 2018;:k3845 10.1136/bmj.k3845
• The effect of rutin on cisplatin-induced oxidative cardiac damage in rats Cite
  Topal I. The effect of rutin on cisplatin-induced oxidative cardiac damage in rats. The Anatolian Journal of Cardiology. Kare Publishing; 2018; 10.14744/anatoljcardiol.2018.32708
• Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients Cite
  Henry ML, Niu J, Zhang N, Giordano SH, Chavez-MacGregor M. Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients. JACC: Cardiovascular Imaging. Elsevier BV; 2018; 11:1084-1093 10.1016/j.jcmg.2018.06.005
• Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity? Cite
  Govender J, Loos B, Marais E, Engelbrecht A. Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity?. Toxicology and Applied Pharmacology. Elsevier BV; 2018; 358:86-101 10.1016/j.taap.2018.06.031
• Anti-tumor effects of propranolol: Adjuvant activity on a transplanted murine breast cancer model Cite
  Ashrafi S, Shapouri R, Shirkhani A, Mahdavi M. Anti-tumor effects of propranolol: Adjuvant activity on a transplanted murine breast cancer model. Biomedicine & Pharmacotherapy. Elsevier BV; 2018; 104:45-51 10.1016/j.biopha.2018.05.002
• Incidence and risk factors for congestive heart failure in patients with early breast cancer who received anthracycline and/or trastuzumab: a big data analysis of the Korean Health Insurance Review and Assessment service database Cite
  Choi JY, Cho EY, Choi YJ, Lee JH, Jung SP, Cho KR, et al. Incidence and risk factors for congestive heart failure in patients with early breast cancer who received anthracycline and/or trastuzumab: a big data analysis of the Korean Health Insurance Review and Assessment service database. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 171:181-188 10.1007/s10549-018-4809-8
• Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer Cite
  Veronese P, Hachul DT, Scanavacca MI, Hajjar LA, Wu TC, Sacilotto L, et al. Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer. PLOS ONE. Public Library of Science (PLoS); 2018; 13:e0196763 10.1371/journal.pone.0196763
• Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model Cite
  Bose C, Awasthi S, Sharma R, Beneš H, Hauer-Jensen M, Boerma M, et al. Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model. PLOS ONE. Public Library of Science (PLoS); 2018; 13:e0193918 10.1371/journal.pone.0193918
• Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity Cite
  Avila MS, Ayub-Ferreira SM, de Barros Wanderley MR, das Dores Cruz F, Gonçalves Brandão SM, Rigaud VOC, et al. Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity. Journal of the American College of Cardiology. Elsevier BV; 2018; 71:2281-2290 10.1016/j.jacc.2018.02.049
• The risk of cardiovascular disease following breast cancer by Framingham risk score Cite
  Gernaat SAM, Boer JMA, van den Bongard DHJ, Maas AHEM, van der Pol CC, Bijlsma RM, et al. The risk of cardiovascular disease following breast cancer by Framingham risk score. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 170:119-127 10.1007/s10549-018-4723-0
• Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it Cite
  Li S, Yuan S, Zhao Q, Wang B, Wang X, Li K. Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it. Biomedicine & Pharmacotherapy. Elsevier BV; 2018; 100:441-447 10.1016/j.biopha.2018.02.055
• Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2 Cite
  Ganz PA, Romond EH, Cecchini RS, Rastogi P, Geyer CE, Swain SM, et al. Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:3942-3948 10.1200/jco.2017.74.1165
• Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly- N -acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma Cite
  El-Ashmawy NE, Khedr EG, Ebeid EM, Salem ML, Zidan AA, Mosalam EM. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly- N -acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma. European Journal of Pharmaceutical Sciences. Elsevier BV; 2017; 109:525-532 10.1016/j.ejps.2017.09.012
• Calcium channel blockers and breast cancer incidence: An updated systematic review and meta-analysis of the evidence Cite
  Wright CM, Moorin RE, Chowdhury EK, Stricker BH, Reid CM, Saunders CM, et al. Calcium channel blockers and breast cancer incidence: An updated systematic review and meta-analysis of the evidence. Cancer Epidemiology. Elsevier BV; 2017; 50:113-124 10.1016/j.canep.2017.08.012
• Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER–Medicare Population Cite
  Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER–Medicare Population. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2017; 26:1603-1610 10.1158/1055-9965.epi-17-0346
• Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study Cite
  Spera G, Fresco R, Fung H, Dyck J, Pituskin E, Paterson I, et al. Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study. Annals of Oncology. Elsevier BV; 2017; 28:1836-1841 10.1093/annonc/mdx264
• Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative Cite
  Brasky TM, Krok-Schoen JL, Liu J, Chlebowski RT, Freudenheim JL, Lavasani S, et al. Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2017; 26:1345-1348 10.1158/1055-9965.epi-17-0096
• Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: A proof-of-concept RCT Cite
  Kirkham A, Shave R, Bland K, Bovard J, Eves N, Gelmon K, et al. Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: A proof-of-concept RCT. International Journal of Cardiology. Elsevier BV; 2017; 245:263-270 10.1016/j.ijcard.2017.07.037
• Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-analysis of observational studies Cite
  Osman MH, Farrag E, Selim M, Osman MS, Hasanine A, Selim A. Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-analysis of observational studies. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0178611 10.1371/journal.pone.0178611
• Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study Cite
  Spera G, Fresco R, Fung H, Dyck J, Pituskin E, Paterson I, et al. Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study. Annals of Oncology. Elsevier BV; 2017; 28:1836-1841 10.1093/annonc/mdx264
• Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study Cite
  Boyd A, Stoodley P, Richards D, Hui R, Harnett P, Vo K, et al. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0175544 10.1371/journal.pone.0175544
• Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy Cite
  Di Biase S, Shim HS, Kim KH, Vinciguerra M, Rappa F, Wei M, et al. Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy. PLOS Biology. Public Library of Science (PLoS); 2017; 15:e2001951 10.1371/journal.pbio.2001951
• Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis Cite
  Abdel-Qadir H, Ong G, Fazelzad R, Amir E, Lee D, Thavendiranathan P, et al. Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis. Annals of Oncology. Elsevier BV; 2017; 28:628-633 10.1093/annonc/mdw671
• Inhibitory Effect of Fruit Juices on the Doxorubicin Metabolizing Activity of Carbonyl Reductase 1 Cite
  Miura T, Nagai K, Kaneshiro S, Taketomi A, Nakabayashi T, Konishi H, et al. Inhibitory Effect of Fruit Juices on the Doxorubicin Metabolizing Activity of Carbonyl Reductase 1. Drug Metabolism Letters. Bentham Science Publishers Ltd.; 2017; 11 10.2174/1872312811666170309153025
• The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma Cite
  Coulson R, Liew SH, Connelly AA, Yee NS, Deb S, Kumar B, et al. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma. Oncotarget. Impact Journals, LLC; 2017; 8:18640-18656 10.18632/oncotarget.15553
• Is Beta-Blocker Use Beneficial in Breast Cancer? A Meta-Analysis Cite
  Kim HY, Jung YJ, Lee SH, Jung HJ, Pak K. Is Beta-Blocker Use Beneficial in Breast Cancer? A Meta-Analysis. Oncology. S. Karger AG; 2017; 92:264-268 10.1159/000455143
• Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter? Cite
  Alarid-Escudero F, Blaes AH, Kuntz KM. Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter?. The Breast Journal. Wiley; 2017; 23:401-409 10.1111/tbj.12757
• Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers Cite
  Henninger C, Fritz G. Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers. Cell Death & Disease. Springer Science and Business Media LLC; 2017; 8:e2564-e2564 10.1038/cddis.2016.418
• A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer Cite
  Gargiulo L, May M, Rivero EM, Copsel S, Lamb C, Lydon J, et al. A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. Springer Science and Business Media LLC; 2017; 22:43-57 10.1007/s10911-017-9371-1
• Rutin attenuates doxorubicin-induced cardiotoxicity via regulating autophagy and apoptosis Cite
  Ma Y, Yang L, Ma J, Lu L, Wang X, Ren J, et al. Rutin attenuates doxorubicin-induced cardiotoxicity via regulating autophagy and apoptosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Elsevier BV; 2017; 1863:1904-1911 10.1016/j.bbadis.2016.12.021
• L-type calcium channels regulate filopodia stability and cancer cell invasion downstream of integrin signalling Cite
  Jacquemet G, Baghirov H, Georgiadou M, Sihto H, Peuhu E, Cettour-Janet P, et al. L-type calcium channels regulate filopodia stability and cancer cell invasion downstream of integrin signalling. Nature Communications. Springer Science and Business Media LLC; 2016; 7 10.1038/ncomms13297
• Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials Cite
  Khosrow-Khavar F, Filion K, Al-Qurashi S, Torabi N, Bouganim N, Suissa S, et al. Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials. Annals of Oncology. Elsevier BV; 2017; 28:487-496 10.1093/annonc/mdw673
• (−)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice Cite
  Yao Y, Liu X, Li W, Shi Z, Yan Y, Wang L, et al. (−)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice. Life Sciences. Elsevier BV; 2017; 180:151-159 10.1016/j.lfs.2016.12.004
• Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity Cite
  Pituskin E, Mackey JR, Koshman S, Jassal D, Pitz M, Haykowsky MJ, et al. Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 35:870-877 10.1200/jco.2016.68.7830
• Melissa officinalis Protects against Doxorubicin-Induced Cardiotoxicity in Rats and Potentiates Its Anticancer Activity on MCF-7 Cells Cite
  Hamza AA, Ahmed MM, Elwey HM, Amin A. Melissa officinalis Protects against Doxorubicin-Induced Cardiotoxicity in Rats and Potentiates Its Anticancer Activity on MCF-7 Cells. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0167049 10.1371/journal.pone.0167049
• Cardioprotective Effect of Selenium Against Cyclophosphamide-Induced Cardiotoxicity in Rats Cite
  Gunes S, Sahinturk V, Karasati P, Sahin IK, Ayhanci A. Cardioprotective Effect of Selenium Against Cyclophosphamide-Induced Cardiotoxicity in Rats. Biological Trace Element Research. Springer Science and Business Media LLC; 2016; 177:107-114 10.1007/s12011-016-0858-1
• Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway Cite
  Huang P, Kuo W, Shen C, Chen Y, Lin Y, Ho T, et al. Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway. International Journal of Molecular Sciences. MDPI AG; 2016; 17:1588 10.3390/ijms17091588
• Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis Cite
  Guenancia C, Lefebvre A, Cardinale D, Yu AF, Ladoire S, Ghiringhelli F, et al. Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:3157-3165 10.1200/jco.2016.67.4846
• Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells Cite
  Das S, Filippone SM, Williams DS, Das A, Kukreja RC. Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells. Molecular and Cellular Biochemistry. Springer Science and Business Media LLC; 2016; 421:89-101 10.1007/s11010-016-2789-8
• Ameliorative Influence of Dietary Dates on Doxorubicin-Induced Cardiac Toxicity Cite
  Abdalla AN, Hassan Almaliki W, Hasan Mukhtar M, Anwar F, Shahid I, Menshawi SA, et al. Ameliorative Influence of Dietary Dates on Doxorubicin-Induced Cardiac Toxicity. Pharmacology & Pharmacy. Scientific Research Publishing, Inc.; 2016; 07:343-353 10.4236/pp.2016.78042
• The Use of Telmisartan and the Incidence of Cancer Cite
  Tascilar K, Azoulay L, Dell’Aniello S, Bartels DB, Suissa S. The Use of Telmisartan and the Incidence of Cancer. American Journal of Hypertension. Oxford University Press (OUP); 2016;:hpw095 10.1093/ajh/hpw095
• Resting heart rate as a prognostic factor for mortality in patients with breast cancer Cite
  Lee DH, Park S, Lim SM, Lee MK, Giovannucci EL, Kim JH, et al. Resting heart rate as a prognostic factor for mortality in patients with breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 159:375-384 10.1007/s10549-016-3938-1
• Abstract LB-257: The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma Cite
  Coulson RS, Deb S, Ernst M, Allen A, Chand AL. Abstract LB-257: The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma. Clinical Research (Excluding Clinical Trials). American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-lb-257
• The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study Cite
  Gómez-Acebo I, Dierssen-Sotos T, Palazuelos C, Pérez-Gómez B, Lope V, Tusquets I, et al. The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0159672 10.1371/journal.pone.0159672
• Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression Cite
  Dong Q, Chen L, Lu Q, Sharma S, Li L, Morimoto S, et al. Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression. British Journal of Pharmacology. Wiley; 2014; 171:4440-4454 10.1111/bph.12795
• Quercetin-induced cardioprotection against doxorubicin cytotoxicity Cite
  Chen J, Hu R, Chou H. Quercetin-induced cardioprotection against doxorubicin cytotoxicity. Journal of Biomedical Science. Springer Science and Business Media LLC; 2013; 20:95 10.1186/1423-0127-20-95
• Abstract 260: Quercetin protects from doxorubicin induced vascular toxicity but impairs its cytotoxic profile in breast cancer cells Cite
  Assiri HA, Al-Abbasi FA, El-Bassossy HM, El-Moselhy MA, Al-Abd AM. Abstract 260: Quercetin protects from doxorubicin induced vascular toxicity but impairs its cytotoxic profile in breast cancer cells. Experimental and Molecular Therapeutics. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-260
• Anthracycline-Free Neoadjuvant Chemotherapy Ensures Higher Rates of Pathologic Complete Response in Breast Cancer Cite
  De Iuliis F, Salerno G, Corvino R, D'Aniello D, Cefalì K, Taglieri L, et al. Anthracycline-Free Neoadjuvant Chemotherapy Ensures Higher Rates of Pathologic Complete Response in Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2017; 17:34-40 10.1016/j.clbc.2016.06.010
• Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women Cite
  Wilson LE, D’Aloisio AA, Sandler DP, Taylor JA. Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women. Breast Cancer Research. Springer Science and Business Media LLC; 2016; 18 10.1186/s13058-016-0720-6
• Crocin treatment prevents doxorubicin-induced cardiotoxicity in rats Cite
  Razmaraii N, Babaei H, Mohajjel Nayebi A, Assadnassab G, Ashrafi Helan J, Azarmi Y. Crocin treatment prevents doxorubicin-induced cardiotoxicity in rats. Life Sciences. Elsevier BV; 2016; 157:145-151 10.1016/j.lfs.2016.06.012
• Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer Cite
  Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, et al. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:2743-2749 10.1200/jco.2015.65.6603
• Breast Cancer Therapy–Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study Cite
  Thavendiranathan P, Abdel-Qadir H, Fischer HD, Camacho X, Amir E, Austin PC, et al. Breast Cancer Therapy–Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:2239-2246 10.1200/jco.2015.65.1505
• Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts Cite
  Chen P, Hou C, Shibu MA, Day CH, Pai P, Liu Z, et al. Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts. Environmental Toxicology. Wiley; 2016; 32:679-689 10.1002/tox.22270
• Cardiotoxicity of breast cancer treatment: no easy solution for an important long-term problem Cite
  van der Meer P, Gietema JA, Suter TM, van Veldhuisen DJ. Cardiotoxicity of breast cancer treatment: no easy solution for an important long-term problem. European Heart Journal. Oxford University Press (OUP); 2016; 37:1681-1683 10.1093/eurheartj/ehw133
• Use of Calcium Channel Blockers and Risk of Breast Cancer Cite
  Azoulay L, Soldera S, Yin H, Bouganim N. Use of Calcium Channel Blockers and Risk of Breast Cancer. Epidemiology. Ovid Technologies (Wolters Kluwer Health); 2016; 27:594-601 10.1097/ede.0000000000000483
• The β 2 ‐adrenoceptor activates a positive cAMP‐calcium feedforward loop to drive breast cancer cell invasion Cite
  Pon CK, Lane JR, Sloan EK, Halls ML. The β 2 ‐adrenoceptor activates a positive cAMP‐calcium feedforward loop to drive breast cancer cell invasion. The FASEB Journal. Wiley; 2015; 30:1144-1154 10.1096/fj.15-277798
• Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis Cite
  Raimondi S, Botteri E, Munzone E, Cipolla C, Rotmensz N, DeCensi A, et al. Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis. International Journal of Cancer. Wiley; 2016; 139:212-219 10.1002/ijc.30062
• Cardiomyopathy Associated With Targeted Therapy for Breast Cancer Cite
  Sivagnanam K, Rahman ZU, Paul T. Cardiomyopathy Associated With Targeted Therapy for Breast Cancer. The American Journal of the Medical Sciences. Elsevier BV; 2016; 351:194-199 10.1016/j.amjms.2015.11.014
• Antihypertensive agents and the risk of breast cancer in women aged 55 years and older Cite
  Chang C, Chiang C, Yen C, Wu L, Lin J, Lai M. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older. Journal of Hypertension. Ovid Technologies (Wolters Kluwer Health); 2016; 34:558-566 10.1097/hjh.0000000000000813
• Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer Cite
  Dang C, Guo H, Najita J, Yardley D, Marcom K, Albain K, et al. Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer. JAMA Oncology. American Medical Association (AMA); 2016; 2:29 10.1001/jamaoncol.2015.3709
• Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells Cite
  Talarico G, Orecchioni S, Dallaglio K, Reggiani F, Mancuso P, Calleri A, et al. Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep18673
• Quercetin and the mitochondria: A mechanistic view Cite
  de Oliveira MR, Nabavi SM, Braidy N, Setzer WN, Ahmed T, Nabavi SF. Quercetin and the mitochondria: A mechanistic view. Biotechnology Advances. Elsevier BV; 2016; 34:532-549 10.1016/j.biotechadv.2015.12.014
• Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors Cite
  Boekel NB, Schaapveld M, Gietema JA, Russell NS, Poortmans P, Theuws JC, et al. Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2016; 94:1061-1072 10.1016/j.ijrobp.2015.11.040
• The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference Cite
  He R, He Y, Tang Y, Zhou H, McLeod HL, Liu J. The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference. Pharmacogenomics. Future Medicine Ltd; 2016; 17:74-9 10.2217/pgs.15.152
• The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study Cite
  Goldhar HA, Yan AT, Ko DT, Earle CC, Tomlinson GA, Trudeau ME, et al. The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study. Journal of the National Cancer Institute. Oxford University Press (OUP); 2015; 108:djv301 10.1093/jnci/djv301
• Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab Cite
  Cao L, Cai G, Chang C, Yang Z, Feng Y, Yu X, et al. Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab. Oncotarget. Impact Journals, LLC; 2015; 7:1042-1054 10.18632/oncotarget.6053
• Late cardiac morbidity of adjuvant radiotherapy for early breast cancer – A population-based study Cite
  Leung HW, Chan AL, Muo C. Late cardiac morbidity of adjuvant radiotherapy for early breast cancer – A population-based study. Journal of Cardiology. Elsevier BV; 2016; 67:567-571 10.1016/j.jjcc.2015.07.009
• Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy Cite
  de Azambuja E, Ameye L, Diaz M, Vandenbossche S, Aftimos P, Hernández SB, et al. Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy. European Journal of Cancer. Elsevier BV; 2015; 51:2517-2524 10.1016/j.ejca.2015.08.011
• The Role of Grape Seed Extract in the Treatment of Chemo/Radiotherapy Induced Toxicity: A Systematic Review of Preclinical Studies Cite
  Olaku OO, Ojukwu MO, Zia FZ, White JD. The Role of Grape Seed Extract in the Treatment of Chemo/Radiotherapy Induced Toxicity: A Systematic Review of Preclinical Studies. Nutrition and Cancer. Informa UK Limited; 2015; 67:730-740 10.1080/01635581.2015.1029639
• β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis Cite
  Childers WK, Hollenbeak CS, Cheriyath P. β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis. Clinical Breast Cancer. Elsevier BV; 2015; 15:426-431 10.1016/j.clbc.2015.07.001
• Resveratrol, a polyphenol phytoalexin, protects against doxorubicin‐induced cardiotoxicity Cite
  Gu J, Hu W, Zhang D. Resveratrol, a polyphenol phytoalexin, protects against doxorubicin‐induced cardiotoxicity. Journal of Cellular and Molecular Medicine. Wiley; 2015; 19:2324-2328 10.1111/jcmm.12633
• Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor–Positive Invasive Breast Cancer Cite
  Chen L, Malone KE, Li CI. Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor–Positive Invasive Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2015; 24:1423-1426 10.1158/1055-9965.epi-15-0547
• Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusionin vitro Cite
  Chahine N, Nader M, Duca L, Martiny L, Chahine R. Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusionin vitro. Drug and Chemical Toxicology. Informa UK Limited; 2015; 39:87-96 10.3109/01480545.2015.1036281
• Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial Cite
  Eldredge-Hindy H, Lockamy V, Crawford A, Nettleton V, Werner-Wasik M, Siglin J, et al. Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial. Practical Radiation Oncology. Elsevier BV; 2015; 5:4-10 10.1016/j.prro.2014.06.004
• The flavonoid quercetin: Possible solution for anthracycline-induced cardiotoxicity and multidrug resistance Cite
  Czepas J, Gwoździński K. The flavonoid quercetin: Possible solution for anthracycline-induced cardiotoxicity and multidrug resistance. Biomedicine & Pharmacotherapy. Elsevier BV; 2014; 68:1149-1159 10.1016/j.biopha.2014.10.013
• Chronic heart damage following doxorubicin treatment is alleviated by lovastatin Cite
  Henninger C, Huelsenbeck S, Wenzel P, Brand M, Huelsenbeck J, Schad A, et al. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin. Pharmacological Research. Elsevier BV; 2015; 91:47-56 10.1016/j.phrs.2014.11.003
• Breast Cancer Laterality Does Not Influence Survival in a Large Modern Cohort: Implications for Radiation-Related Cardiac Mortality Cite
  Rutter CE, Chagpar AB, Evans SB. Breast Cancer Laterality Does Not Influence Survival in a Large Modern Cohort: Implications for Radiation-Related Cardiac Mortality. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014; 90:329-334 10.1016/j.ijrobp.2014.06.030
• Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin Cite
  Govender J, Loos B, Marais E, Engelbrecht A. Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin. Journal of Pineal Research. Wiley; 2014; 57:367-380 10.1111/jpi.12176
• Can short-term fasting protect against doxorubicin-induced cardiotoxicity? Cite
  Dirks-Naylor AJ. Can short-term fasting protect against doxorubicin-induced cardiotoxicity?. World Journal of Biological Chemistry. Baishideng Publishing Group Inc.; 2014; 5:269 10.4331/wjbc.v5.i3.269
• Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies Cite
  Li W, Shi Q, Wang W, Liu J, Li Q, Hou F. Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e105801 10.1371/journal.pone.0105801
• Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast Cite
  Boekel NB, Schaapveld M, Gietema JA, Rutgers EJT, Versteegh MIM, Visser O, et al. Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2014; 106 10.1093/jnci/dju156
• Association between calcium channel blockers and breast cancer: a meta-analysis of observational studies Cite
  Chen Q, Zhang Q, Zhong F, Guo S, Jin Z, Shi W, et al. Association between calcium channel blockers and breast cancer: a meta-analysis of observational studies. Pharmacoepidemiology and Drug Safety. Wiley; 2014; 23:711-718 10.1002/pds.3645
• Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer Cite
  Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJA, Fujii M, et al. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 144:405-416 10.1007/s10549-014-2870-5
• Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation Cite
  Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Prasad SVN, et al. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. Journal of Clinical Investigation. American Society for Clinical Investigation; 2014; 124:617-630 10.1172/jci72931
• Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity Cite
  Lotrionte M, Biondi-Zoccai G, Abbate A, Lanzetta G, D'Ascenzo F, Malavasi V, et al. Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity. The American Journal of Cardiology. Elsevier BV; 2013; 112:1980-1984 10.1016/j.amjcard.2013.08.026
• Dietary Trans Fats Enhance Doxorubicin-Induced Cardiotoxicity in Mice Cite
  Mong M, Hsia T, Yin M. Dietary Trans Fats Enhance Doxorubicin-Induced Cardiotoxicity in Mice. Journal of Food Science. Wiley; 2013; 78:H1621-H1628 10.1111/1750-3841.12257
• Protective effect of melatonin against Adriamycin-induced cardiotoxicity Cite
  ZHANG Y, LI L, XIANG C, MA Z, MA T, ZHU S. Protective effect of melatonin against Adriamycin-induced cardiotoxicity. Experimental and Therapeutic Medicine. Spandidos Publications; 2013; 5:1496-1500 10.3892/etm.2013.989
• Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice Cite
  Dolinsky VW, Rogan KJ, Sung MM, Zordoky BN, Haykowsky MJ, Young ME, et al. Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. American Journal of Physiology-Endocrinology and Metabolism. American Physiological Society; 2013; 305:E243-E253 10.1152/ajpendo.00044.2013
• Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study Cite
  Sørensen GV, Ganz PA, Cole SW, Pedersen LA, Sørensen HT, Cronin-Fenton DP, et al. Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2013; 31:2265-2272 10.1200/jco.2012.43.9190
• AFRICAN AMERICAN RACE IS A CORRELATE OF HEART FAILURE IN BREAST CANCER SURVIVORS: A STUDY OF 26,347 WOMEN IDENTIFIED WITH BREAST CANCER FROM 1973-2007 Cite
  Valina-Toth AL, Zavodnik T, Seicean S, Plana J, Marwick T. AFRICAN AMERICAN RACE IS A CORRELATE OF HEART FAILURE IN BREAST CANCER SURVIVORS: A STUDY OF 26,347 WOMEN IDENTIFIED WITH BREAST CANCER FROM 1973-2007. Journal of the American College of Cardiology. Elsevier BV; 2013; 61:E580 10.1016/s0735-1097(13)60580-x
• 3,3′-Diindolymethane ameliorates adriamycin-induced cardiac fibrosis via activation of a BRCA1-dependent anti-oxidant pathway Cite
  Yao Z, Hu W, Yin S, Huang Z, Zhu Q, Chen J, et al. 3,3′-Diindolymethane ameliorates adriamycin-induced cardiac fibrosis via activation of a BRCA1-dependent anti-oxidant pathway. Pharmacological Research. Elsevier BV; 2013; 70:139-146 10.1016/j.phrs.2013.01.006
• Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer Cite
  Chen J, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP. Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer. Journal of the American College of Cardiology. Elsevier BV; 2012; 60:2504-2512 10.1016/j.jacc.2012.07.068
• Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study Cite
  Bowles EJA, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, et al. Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2012; 104:1293-1305 10.1093/jnci/djs317
• Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: A systematic review of randomized controlled trials Cite
  Brollo J, Curigliano G, Disalvatore D, Marrone BF, Criscitiello C, Bagnardi V, et al. Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: A systematic review of randomized controlled trials. Cancer Treatment Reviews. Elsevier BV; 2013; 39:44-50 10.1016/j.ctrv.2012.03.009
• Long-term toxic effects of adjuvant chemotherapy in breast cancer Cite
  Azim H, de Azambuja E, Colozza M, Bines J, Piccart M. Long-term toxic effects of adjuvant chemotherapy in breast cancer. Annals of Oncology. Elsevier BV; 2011; 22:1939-1947 10.1093/annonc/mdq683
• Effect of low-protein diet on anthracycline pharmacokinetics and cardiotoxicity Cite
  El-Demerdash E, Ali AA, El-Taher DE, Hamada FM. Effect of low-protein diet on anthracycline pharmacokinetics and cardiotoxicity. Journal of Pharmacy and Pharmacology. Wiley; 2011; 64:344-352 10.1111/j.2042-7158.2011.01413.x
• Naproxen aggravates doxorubicin-induced cardiomyopathy in rats Cite
  Pathan R, Singh B, Pillai K, Dubey K. Naproxen aggravates doxorubicin-induced cardiomyopathy in rats. Indian Journal of Pharmacology. Medknow; 2010; 42:44 10.4103/0253-7613.62411
• Grape Seed and Skin Extract Protects Against Acute Chemotherapy Toxicity induced by Doxorubicin in Rat Heart Cite
  Mokni M, Hamlaoui-Guesmi S, Amri M, Marzouki L, Limam F, Aouani E. Grape Seed and Skin Extract Protects Against Acute Chemotherapy Toxicity induced by Doxorubicin in Rat Heart. Cardiovascular Toxicology. Springer Science and Business Media LLC; 2012; 12:158-165 10.1007/s12012-012-9155-1
• Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats Cite
  Swamy A, Gulliaya S, Thippeswamy A, Koti B, Manjula D. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian Journal of Pharmacology. Medknow; 2012; 44:73 10.4103/0253-7613.91871
• Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro Cite
  Xiao J, Sun G, Sun B, Wu Y, He L, Wang X, et al. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Toxicology. Elsevier BV; 2012; 292:53-62 10.1016/j.tox.2011.11.018
• Adjuvant Trastuzumab in HER2-Positive Breast Cancer Cite
  Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, et al. Adjuvant Trastuzumab in HER2-Positive Breast Cancer. New England Journal of Medicine. Massachusetts Medical Society; 2011; 365:1273-1283 10.1056/nejmoa0910383
• Pathology of late-onset anthracycline cardiomyopathy Cite
  Bernaba BN, Chan JB, Lai CK, Fishbein MC. Pathology of late-onset anthracycline cardiomyopathy. Cardiovascular Pathology. Elsevier BV; 2010; 19:308-311 10.1016/j.carpath.2009.07.004
• Effects of n-3 Polyunsaturated Fatty Acids on Left Ventricular Function and Functional Capacity in Patients With Dilated Cardiomyopathy Cite
  Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, et al. Effects of n-3 Polyunsaturated Fatty Acids on Left Ventricular Function and Functional Capacity in Patients With Dilated Cardiomyopathy. Journal of the American College of Cardiology. Elsevier BV; 2011; 57:870-879 10.1016/j.jacc.2010.11.017
• Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology Cite
  Eschenhagen T, Force T, Ewer MS, de Keulenaer GW, Suter TM, Anker SD, et al. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. Wiley; 2011; 13:1-10 10.1093/eurjhf/hfq213
• Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation Cite
  Konishi M, Haraguchi G, Ohigashi H, Ishihara T, Saito K, Nakano Y, et al. Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation. Cardiovascular Research. Oxford University Press (OUP); 2010; 89:309-319 10.1093/cvr/cvq335
• Early identification of trastuzumab-related cardiotoxicity with speckle-tracking echocardiography. Cite
  Maurea N, De Lorenzo C, Coppola C, Ragone G, Di Pietro E, Schiattarella G, et al. Early identification of trastuzumab-related cardiotoxicity with speckle-tracking echocardiography.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11096-e11096 10.1200/jco.2010.28.15_suppl.e11096
• Abstract 3223: Severe dietary restriction enhances cancer treatment: Protecting normal cells and sensitizing malignant cells to chemotherapy by fasting Cite
  Lee C, Safdie F, Raffaghello L, Wei M, Longo V. Abstract 3223: Severe dietary restriction enhances cancer treatment: Protecting normal cells and sensitizing malignant cells to chemotherapy by fasting. Cellular and Molecular Biology. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-3223